Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-25-012691

Options or other derivatives

  • Chief Medical Officer acquired 289,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Jones Mitchell Lawrence Chief Medical Officer 2025-09-04 Grant or award · Phantom Units +289,000 289,000 D
Loading xslF345X05/ownership.xml…